Abstract
Objectives
The objective of the present study is to compare the effect of systemic adjunctive use of azithromycin with amoxicillin/metronidazole to scaling and root planing (SRP) in a clinical study.
Materials and methods
Data from 60 individuals with chronic periodontitis were evaluated after full-mouth SRP. Antibiotics were given from the first day of SRP, in the test group (n = 29), azithromycin for 3 days and, in the control group (n = 31), amoxicillin/metronidazole for7 days. Probing depth (PD), attachment level (AL), and bleeding on probing (BOP) were recorded at baseline and after 3 and 12 months. Gingival crevicular fluid was analyzed for matrix metalloprotease (MMP)-8 and interleukin (IL)-1beta levels. Subgingival plaque was taken for assessment of the major bacteria associated with periodontitis.
Results
In both groups, PD, AL, and BOP were significantly reduced (p < 0.001).
A few significant differences between the groups were found; AL and BOP were significantly better in the test than in the control group at the end of the study (p = 0.020 and 0.009). Periodontopathogens were reduced most in the test group.
Conclusions
A noninferiority of the treatment with azithromycin in comparison with amoxicillin/metronidazole can be stated. The administration of azithromycin could be an alternative to the use of amoxicillin/metronidazole adjunctive to SRP in patients with moderate or severe chronic periodontitis; however, a randomized placebo-controlled multicenter study is needed.
Clinical relevance
Application of azithromycin as a single antibiotic for 3 days might be considered as an additional adjunctive antibiotic to SRP in selected patients.
Similar content being viewed by others
References
Apatzidou DA, Kinane DF (2010) Nonsurgical mechanical treatment strategies for periodontal disease. Dent Clin North Am 54:1–12. doi:10.1016/j.cden.2009.08.006S0011-8532(09)00071-8
Cobb CM (2002) Clinical significance of non-surgical periodontal therapy: an evidence-based perspective of scaling and root planing. J Clin Periodontol 29(Suppl 2):6–16
Sgolastra F, Gatto R, Petrucci A, Monaco A (2012) Effectiveness of systemic amoxicillin/metronidazole as adjunctive therapy to scaling and root planing in the treatment of chronic periodontitis: a systematic review and meta-analysis. J Periodontol 83:1257–1269. doi:10.1902/jop.2012.110625
Zandbergen D, Slot DE, Cobb CM, Van der Weijden FA (2013) The clinical effect of scaling and root planing and the concomitant administration of systemic amoxicillin and metronidazole: a systematic review. J Periodontol 84:332–351. doi:10.1902/jop.2012.120040
Aljateeli M, Giannobile WV, Wang HL (2013) Locally-delivered antibiotics for management of periodontitis: current understanding. J Mich Dent Assoc 95:42–47
Sgolastra F, Severino M, Petrucci A, Gatto R, Monaco A (2014) Effectiveness of metronidazole as an adjunct to scaling and root planing in the treatment of chronic periodontitis: a systematic review and meta-analysis. J Periodontal Res 49:10–19. doi:10.1111/jre.12089
Miranda TS, Feres M, Perez-Chaparro PJ, Faveri M, Figueiredo LC, Tamashiro NS, Bastos MF, Duarte PM (2014) Metronidazole and amoxicillin as adjuncts to scaling and root planing for the treatment of type 2 diabetic subjects with periodontitis: 1-year outcomes of a randomized placebo-controlled clinical trial. J Clin Periodontol 41:890–899. doi:10.1111/jcpe.12282
Preus HR, Scheie AA, Baelum V (2014) Letter to the editor: Re: The clinical effect of scaling and root planing and the concomitant administration of systemic amoxicillin and metronidazole: a systematic review; Re: Effectiveness of systemic amoxicillin/metronidazole as adjunctive therapy to scaling and root planing in the treatment of chronic periodontitis: a systematic review and meta-analysis; Re: Effectiveness of systemic amoxicillin/metronidazole as an adjunctive therapy to full-mouth scaling and root planing in the treatment of aggressive periodontitis: a systematic review and meta-analysis. J Periodontol 85:374–384. doi:10.1902/jop.2014.130379
Muniz FW, de Oliveira CC, de Sousa CR, Moreira MM, de Moraes ME, Martins RS (2013) Azithromycin: a new concept in adjuvant treatment of periodontitis. Eur J Pharmacol 705:135–139. doi:10.1016/j.ejphar.2013.02.044S0014-2999(13)00153-2
Parnham MJ, Erakovic Haber V, Giamarellos-Bourboulis EJ, Perletti G, Verleden GM, Vos R (2014) Azithromycin: mechanisms of action and their relevance for clinical applications. Pharmacol Ther 143:225–245. doi:10.1016/j.pharmthera.2014.03.003S0163-7258(14)00055-2
Gannon SC, Cantley MD, Haynes DR, Hirsch R, Bartold PM (2013) Azithromycin suppresses human osteoclast formation and activity in vitro. J Cell Physiol 228:1098–1107. doi:10.1002/jcp.24259
Doyle CJ, Fitzsimmons TR, Marchant C, Dharmapatni AA, Hirsch R, Bartold PM (2015) Azithromycin suppresses P. gingivalis LPS-induced pro-inflammatory cytokine and chemokine production by human gingival fibroblasts in vitro. Clin Oral Investig 19:221–227. doi:10.1007/s00784-014-1249-7
Oteo A, Herrera D, Figuero E, O’Connor A, Gonzalez I, Sanz M (2010) Azithromycin as an adjunct to scaling and root planing in the treatment of Porphyromonas gingivalis-associated periodontitis: a pilot study. J Clin Periodontol 37:1005–1015. doi:10.1111/j.1600-051X.2010.01607.xCPE1607
Haas AN, de Castro GD, Moreno T, Susin C, Albandar JM, Oppermann RV, Rosing CK (2008) Azithromycin as an adjunctive treatment of aggressive periodontitis: 12-months randomized clinical trial. J Clin Periodontol 35:696–704. doi:10.1111/j.1600-051X.2008.01254.xCPE1254
Yashima A, Gomi K, Maeda N, Arai T (2009) One-stage full-mouth versus partial-mouth scaling and root planing during the effective half-life of systemically administered azithromycin. J Periodontol 80:1406–1413. doi:10.1902/jop.2009.090067
Haas AN, Seleme F, Segatto P, Susin C, Albandar J, Oppermann RV, Fontanella VR, Rosing CK (2012) Azithromycin as an adjunctive treatment of aggressive periodontitis: radiographic findings of a 12-month randomized clinical trial. Am J Dent 25:215–219
Han B, Emingil G, Ozdemir G, Tervahartiala T, Vural C, Atilla G, Baylas H, Sorsa T (2012) Azithromycin as an adjunctive treatment of generalized severe chronic periodontitis: clinical, microbiologic, and biochemical parameters. J Periodontol 83:1480–1491. doi:10.1902/jop.2012.110519
Emingil G, Han B, Ozdemir G, Tervahartiala T, Vural C, Atilla G, Baylas H, Sorsa T (2012) Effect of azithromycin, as an adjunct to nonsurgical periodontal treatment, on microbiological parameters and gingival crevicular fluid biomarkers in generalized aggressive periodontitis. J Periodontal Res 47:729–739. doi:10.1111/j.1600-0765.2012.01488.x
Sampaio E, Rocha M, Figueiredo LC, Faveri M, Duarte PM, Gomes Lira EA, Feres M (2011) Clinical and microbiological effects of azithromycin in the treatment of generalized chronic periodontitis: a randomized placebo-controlled clinical trial. J Clin Periodontol 38:838–846. doi:10.1111/j.1600-051X.2011.01766.x
Schmidt E, Kaciroti N, Loesche W (2011) Benefits of additional courses of systemic azithromycin in periodontal therapy. Gen Dent 59:180–187, quiz 188-9
Armitage GC (1999) Development of a classification system for periodontal diseases and conditions. Ann Periodontol 4:1–6. doi:10.1902/annals.1999.4.1.1
Lange DE, Plagmann HC, Eenboom A, Promesberger A (1977) Clinical methods for the objective evaluation of oral hygiene. Dtsch Zahnarztl Z 32:44–47
Griffiths GS (2003) Formation, collection and significance of gingival crevice fluid. Periodontol 2000(31):32–42
Eick S, Straube A, Guentsch A, Pfister W, Jentsch H (2011) Comparison of real-time polymerase chain reaction and DNA-strip technology in microbiological evaluation of periodontitis treatment. Diagn Microbiol Infect Dis 69:12–20. doi:10.1016/j.diagmicrobio.2010.08.017S0732-8893(10)00346-9
Yang JL, Wang MS, Cheng AC, Pan KC, Li CF, Deng SX (2008) A simple and rapid method for extracting bacterial DNA from intestinal microflora for ERIC-PCR detection. World J Gastroenterol 14:2872–2876
Moher D, Schulz KF, Altman DG (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357:1191–1194
Haffajee AD, Torresyap G, Socransky SS (2007) Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1-year results. J Clin Periodontol 34:243–253. doi:10.1111/j.1600-051X.2006.01040.x
Axelsson P, Lindhe J (1981) The significance of maintenance care in the treatment of periodontal disease. J Clin Periodontol 8:281–294
Gaunt F, Devine M, Pennington M, Vernazza C, Gwynnett E, Steen N, Heasman P (2008) The cost-effectiveness of supportive periodontal care for patients with chronic periodontitis. J Clin Periodontol 35:67–82. doi:10.1111/j.1600-051X.2008.01261.xCPE1261
Meyer-Baumer A, Eick S, Mertens C, Uhlmann L, Hagenfeld D, Eickholz P, Kim TS, Cosgarea R (2014) Periodontal pathogens and associated factors in aggressive periodontitis: results 5-17 years after active periodontal therapy. J Clin Periodontol 41:662–672. doi:10.1111/jcpe.12255
Tan KH, Seers CA, Dashper SG, Mitchell HL, Pyke JS, Meuric V, Slakeski N, Cleal SM, Chambers JL, McConville MJ, Reynolds EC (2014) Porphyromonas gingivalis and Treponema denticola exhibit metabolic symbioses. PLoS Pathog 10:e1003955. doi:10.1371/journal.ppat.1003955PPATHOGENS-D-13-02117
Ramich T, Schacher B, Scharf S, Rollke L, Arndt R, Eickholz P, Nickles K (2015) Subgingival plaque sampling after combined mechanical and antibiotic nonsurgical periodontal therapy. Clin Oral Investig 19:27–34. doi:10.1007/s00784-014-1208-3
Lo Bue AM, Rossetti B, Cali G, Nicoletti G, Condorelli F (1997) Antimicrobial interference of a subinhibitory concentration of azithromycin on fimbrial production of Porphyromonas gingivalis. J Antimicrob Chemother 40:653–657
Maezono H, Noiri Y, Asahi Y, Yamaguchi M, Yamamoto R, Izutani N, Azakami H, Ebisu S (2011) Antibiofilm effects of azithromycin and erythromycin on Porphyromonas gingivalis. Antimicrob Agents Chemother 55:5887–5892. doi:10.1128/AAC.05169-11AAC.05169-11
Imperi F, Leoni L, Visca P (2014) Antivirulence activity of azithromycin in Pseudomonas aeruginosa. Front Microbiol 5:178. doi:10.3389/fmicb.2014.00178
Barksby HE, Lea SR, Preshaw PM, Taylor JJ (2007) The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin Exp Immunol 149:217–225. doi:10.1111/j.1365-2249.2007.03441.x
Sorsa T, Tjaderhane L, Salo T (2004) Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis 10:311–318. doi:10.1111/j.1601-0825.2004.01038.x
Uitto VJ (2000) Overall CM and McCulloch C (2003) Proteolytic host cell enzymes in gingival crevice fluid. Periodontol 31:77–104
Hall IH, Schwab UE, Ward ES, Butts JD, Wolford ET, Ives TJ (2002) Disposition and intracellular activity of azithromycin in human THP-1 acute monocytes. Int J Antimicrob Agents 20:348–360
Polancec DS, Munic Kos V, Banjanac M, Vrancic M, Cuzic S, Belamaric D, Parnham MJ, Polancec D, Erakovic Haber V (2012) Azithromycin drives in vitro GM-CSF/IL-4-induced differentiation of human blood monocytes toward dendritic-like cells with regulatory properties. J Leukoc Biol 91:229–243. doi:10.1189/jlb.1210655jlb.1210655
Culic O, Erakovic V, Cepelak I, Barisic K, Brajsa K, Ferencic Z, Galovic R, Glojnaric I, Manojlovic Z, Munic V, Novak-Mircetic R, Pavicic-Beljak V, Sucic M, Veljaca M, Zanic-Grubisic T, Parnham MJ (2002) Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects. Eur J Pharmacol 450:277–289
Ho W, Eubank T, Leblebicioglu B, Marsh C, Walters J (2010) Azithromycin decreases crevicular fluid volume and mediator content. J Dent Res 89:831–835. doi:10.1177/00220345103686500022034510368650
Belibasakis GN, Thurnheer T (2014) Validation of antibiotic efficacy on in vitro subgingival biofilms. J Periodontol 85:343–348. doi:10.1902/jop.2013.130167
Tsaousoglou P, Nietzsche S, Cachovan G, Sculean A, Eick S (2014) Antibacterial activity of moxifloxacin on bacteria associated with periodontitis within a biofilm. J Med Microbiol 63:284–292. doi:10.1099/jmm.0.065441-0jmm.0.065441-0
Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M (2014) A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis 14:13. doi:10.1186/1471-2334-14-131471-2334-14-13
Acknowledgments
The authors appreciate the laboratory work of Stéphanie Larti, Anna Magdon, and Marianne Weibel. They are grateful to Timothy Jones (Institute of Applied Linguistics and Translatology, University of Leipzig) for proofreading and to Walter B. Bürgin, Dipl. Biomed. Ing. (University of Bern), for statistical support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors (Holger Jentsch, Andreas Buchmann, Abel Friedrich, and Sigrun Eick) declare that they have no conflict of interest.
Funding
The study was funded by the participating institutions and partly supported by Hain Diagnostica, Nehren, Germany, who provided the materials for microbiological laboratory analyses.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Holger F. R. Jentsch and Andreas Buchmann contributed equally to this work.
Rights and permissions
About this article
Cite this article
Jentsch, H.F.R., Buchmann, A., Friedrich, A. et al. Nonsurgical therapy of chronic periodontitis with adjunctive systemic azithromycin or amoxicillin/metronidazole. Clin Oral Invest 20, 1765–1773 (2016). https://doi.org/10.1007/s00784-015-1683-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-015-1683-1